UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 145

Sortiert nach

A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes

Clinical endocrinology (Oxford), 2017-08, Vol.87 (2), p.149-155

2017

Volltextzugriff (PDF)

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

Clinical pharmacology and therapeutics, 2010-05, Vol.87 (5), p.572-578

2010

Volltextzugriff (PDF)

Genetic variation in the alpha1B-adrenergic receptor and vascular response

The pharmacogenomics journal, 2017-07, Vol.17 (4), p.366-371

2017

Volltextzugriff (PDF)

Common Genetic Variants of Microsomal Epoxide Hydrolase Affect Warfarin Dose Requirements Beyond the Effect of Cytochrome P450 2C9

Clinical pharmacology and therapeutics, 2005-05, Vol.77 (5), p.365-372

2005

Volltextzugriff (PDF)

Bioavailability of oral vs. subcutaneous low‐dose methotrexate in patients with Crohn's disease

Alimentary pharmacology & therapeutics, 2003-07, Vol.18 (1), p.57-63

2003

Volltextzugriff (PDF)

The Effects of Tadalafil on Cold-induced Vasoconstriction in Patients with Raynaud's Phenomenon

Clinical pharmacology and therapeutics, 2007-04, Vol.81 (4), p.503-509

2007

Volltextzugriff (PDF)

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

The New England journal of medicine, 2009-02, Vol.360 (8), p.753-764

2009

Volltextzugriff (PDF)

Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria

The American journal of tropical medicine and hygiene, 2000-03, Vol.62 (3), p.393

2000

Volltextzugriff (PDF)

Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin

Thrombosis and haemostasis, 2006-02, Vol.95 (2), p.205

2006

Volltextzugriff (PDF)

Over-the-counter vitamin K1-Containing multivitamin supplements disrupt oral anticoagulation in susceptible patients-a prospective trial

Clinical pharmacology and therapeutics, 2004-02, Vol.75 (2), p.P27-P27

2004

Volltextzugriff (PDF)

The effect of genetic polymorphisms on warfarin pharmacodynamics

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P96-P96

2005

Volltextzugriff (PDF)

Tariquidar (TAR, XR-9576) selectively inhibits P-glycoprotein (P-gp) in t-lymphocytes compared to that in the blood-brain barrier (BBB)

Clinical pharmacology and therapeutics, 2005-02, Vol.77 (2), p.P39-P39

2005

Volltextzugriff (PDF)

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

Clinical pharmacology and therapeutics, 2006-09, Vol.80 (3), p.228-234

2006

Volltextzugriff (PDF)

Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction

Thrombosis and haemostasis, 2012-10, Vol.108 (4), p.781

2012

Volltextzugriff (PDF)

Genetic variation in the [α.sub.1A]-adrenergic receptor and phenylephrine-mediated venoconstriction

The pharmacogenomics journal, 2015-07, p.310

2015

Volltextzugriff (PDF)

Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland

Medicine (Baltimore), 2004-03, Vol.83 (2), p.107-113

2004

Volltextzugriff (PDF)

Genetic variation in the [alpha]1A-adrenergic receptor and phenylephrine-mediated venoconstriction

The pharmacogenomics journal, 2015-08, Vol.15 (4), p.310

2015

Volltextzugriff (PDF)

Genetic variation in the alpha sub(1A)-adrenergic receptor and phenylephrine-mediated venoconstriction

The pharmacogenomics journal, 2015-08, Vol.15 (4), p.310-315

2015

Volltextzugriff (PDF)

Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction

The pharmacogenomics journal, 2015-08, Vol.15 (4), p.310-315

2015

Volltextzugriff (PDF)

VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations

Journal of applied genetics, 2014-05, Vol.55 (2), p.163-171

2014

Volltextzugriff (PDF)

Factors Associated With Discontinuation of Home Hemodialysis

American journal of kidney diseases, 2016-04, Vol.67 (4), p.629-637

2016

Volltextzugriff (PDF)

The endoscopic ultrasonographic appearance of Brunner's gland hamartoma

Gastrointestinal endoscopy, 1997-08, Vol.46 (2), p.176-178

1997

Volltextzugriff (PDF)

Specific clinical constellations might mask the genetic over-sensitivity to warfarin

The Israel Medical Association journal, 2002-06, Vol.4 (6), p.475; author reply 475-475; author reply 476

2002

Volltextzugriff (PDF)

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching

Clinical pharmacology and therapeutics, 2003-09, Vol.74 (3), p.215-221

2003

Volltextzugriff (PDF)

1 – 25 von 145

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A genetic risk score that includes common type 2 diabetes risk variants is associated with gestational diabetes

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing

Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy

Genetic variation in the alpha1B-adrenergic receptor and vascular response

Common Genetic Variants of Microsomal Epoxide Hydrolase Affect Warfarin Dose Requirements Beyond the Effect of Cytochrome P450 2C9

Bioavailability of oral vs. subcutaneous low‐dose methotrexate in patients with Crohn's disease

The Effects of Tadalafil on Cold-induced Vasoconstriction in Patients with Raynaud's Phenomenon

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria

Combined genetic profiles of components and regulators of the vitamin K-dependent gamma-carboxylation system affect individual sensitivity to warfarin

Over-the-counter vitamin K1-Containing multivitamin supplements disrupt oral anticoagulation in susceptible patients-a prospective trial

The effect of genetic polymorphisms on warfarin pharmacodynamics

Tariquidar (TAR, XR-9576) selectively inhibits P-glycoprotein (P-gp) in t-lymphocytes compared to that in the blood-brain barrier (BBB)

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity

Effect of the VKORC1 D36Y variant on warfarin dose requirement and pharmacogenetic dose prediction

Genetic variation in the [α.sub.1A]-adrenergic receptor and phenylephrine-mediated venoconstriction

Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland

Genetic variation in the [alpha]1A-adrenergic receptor and phenylephrine-mediated venoconstriction

Genetic variation in the alpha sub(1A)-adrenergic receptor and phenylephrine-mediated venoconstriction

Genetic variation in the α1A-adrenergic receptor and phenylephrine-mediated venoconstriction

VKORC1 Asp36Tyr variant and VKORC1 haplotype diversity in Ashkenazi and Ethiopian populations

Factors Associated With Discontinuation of Home Hemodialysis

The endoscopic ultrasonographic appearance of Brunner's gland hamartoma

Specific clinical constellations might mask the genetic over-sensitivity to warfarin

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching

Suchergebnisse filtern